Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pembrolizumab
Squamous Cell Carcinoma
Diwakar DavarP2B (62)
Plerixafor
Myelodysplastic Syndrome
Stanford UniversityP2B (62)
Polatuzumab Vedotin
B-Cell Non-Hodgkin Lymphoma
Brown UniversityP2B (62)
Polatuzumab Vedotin
Marginal Zone Lymphoma
University of WashingtonP2B (62)
Poly-Iclc
Mucosal Melanoma
Fred Hutchinson Cancer CenterP2B (62)
Prednisone
Primary Central Nervous System Lymphoma
Juan P. Alderuccio, MDP2B (62)
Prednisone
Metastatic Melanoma
National Cancer Institute (NCI)P2B (62)
Pyrotinib
Metastatic Malignant Neoplasm
BeOne MedicinesP2B (62)
Raltitrexed
Rectal Cancer
Fudan UniversityP2B (62)
Regorafenib
Small Cell Lung Carcinoma
Neonc Technologies, Inc.P2B (62)
Relatlimab
Cancer
Bristol-Myers SquibbP2B (62)
Rencofilstat
Metabolic Dysfunction-Associated Steatohepatitis
Hepion Pharmaceuticals, Inc.P2B (62)
Resiquimod
Melanoma
Institut BergoniéP2B (62)
Rocbrutinib
Diffuse Large B-Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P2B (62)
Romidepsin
Mycosis Fungoides
Walter HanelP2B (62)
Ruxolitinib
Essential Thrombocythemia
University of WashingtonP2B (62)
Ruxolitinib
Myelodysplastic Syndrome
Center for International Blood and Marrow Transplant ResearchP2B (62)
Setanaxib
Primary Biliary Cholangitis
Calliditas Therapeutics Suisse SAP2B (62)
Sirolimus
Acute Undifferentiated Leukemia
Masonic Cancer Center, University of MinnesotaP2B (62)
Sirolimus
Leukemia
Masonic Cancer Center, University of MinnesotaP2B (62)
Solriamfetol
Long COVID-19
Duke UniversityP2B (62)
Sorafenib
Chronic Myeloid Leukemia
St. Petersburg State Pavlov Medical UniversityP2B (62)
Sorafenib
Hepatitis B Virus Infection
Mina Alpha LimitedP2B (62)
Sorafenib
Hepatitis C Virus Infection
Mina Alpha LimitedP2B (62)
Sorafenib
Malignant Pancreatic Neoplasm
HonorHealth Research InstituteP2B (62)
Showing 1276 to 1300 of 13,155 assets
PreviousPage 52 of 527Next